Table 2.3.
Dystonia associated with other neurogenetic disorders
Group | Disorder | MIM | Gene | Inheritance | Protein | Phenotype |
---|---|---|---|---|---|---|
Dominant ataxias | SCA1 | 164400 | ATXN1 | AD | Ataxin-1 | Ataxia, slow saccades, dysarthria, corticospinal signs, dystonia |
SCA2 | 183090 | ATXN2 | AD | Ataxin-2 | Ataxia, slow saccades, dysarthria, hyporeflexia, dystonia | |
SCA3 | 109150 | ATXN3 | AD | Ataxin-3 | Ataxia, ophthalmoplegia, parkinsonism, dystonia, spasticity, neuropathy | |
SCA6 | 183086 | CACNA1A | AD | α-1A subunit P/Q voltage-gated Ca2+ channel | Ataxia, nystagmus, dystonia | |
SCA7 | 164500 | ATXN7 | AD | Ataxin-7 | Ataxia, macular degeneration, dystonia, spasticity | |
SCA8 | 608768 | ATXN8 | AD | Ataxin-8 | Ataxia, nystagmus, spasticity, dystonia, sensory neuropathy | |
SCA12 | 604326 | PPP2R2B | AD | Serine/threonine-protein phosphatase 2A 55-kDa regulatory subunit B, β isoform | Ataxia, facial myokymia, action tremor, dystonia, parkinsonism, dementia | |
SCA14 | 605361 | PRKCG | AD | Protein kinase C, gamma | Ataxia, myoclonus, slow saccades, focal dystonia | |
SCA17 | 607136 | TBP | AD | TATA box-binding protein | Ataxia, spasticity, seizures, dystonia, dementia | |
Dentatorubral- pallidoluysian atrophy (DRPLA) | 125370 | ATN1 | AD | Atrophin 1 | Ataxia, myoclonus, seizures, dystonia | |
Recessive ataxias | Friedreich ataxia | 606829 | FXN | AR | Frataxin | Ataxia, nystagmus, optic atrophy, cardiomyopathy, sensory neuropathy, spasticity, dystonia, diabetes, scoliosis, pes cavus |
Ataxia telangiectasia | 208900 | AT | AR | Serine-protein kinase ATM | Ataxia, telangiectasis, oculomotor apraxia, immune deficiency, seizures, dystonia | |
Ataxia with oculomotor apraxia type 1 | 208920 | APTX | AR | Aprataxin | Ataxia, oculomotor apraxia, scoliosis, pes cavus, dystonia, choreoathetosis, neuropathy | |
Ataxia with oculomotor apraxia type 2 | 606002 | SETX | AR | Senataxin | Ataxia, oculomotor apraxia, nystagmus, amyotrophy, dystonia, chorea, neuropathy | |
Ataxia with selective vitamin E deficiency | 277460 | TTPA | AR | α-Tocopherol transfer protein | Ataxia, areflexia, loss of proprioception, dystonia, xanthelasma, tendon xanthomas | |
X-linked ataxias | Mental retardation, X-linked syndromic, Christianson type | 300243 | SLC9A6 | X-linked dominant | Sodium/hydrogen exchanger 6 | Ataxia, spasticity, mental retardation, dysmorphic features, microcephaly, dystonia, autistic |
Dopamine metabolism | AADC deficiency | 608643 | AADC | AR | Aromatic L-amino acid decarboxylase | Psychomotor delay, ptosis, oculogyric crises, dystonia, truncal hypotonia, temperature instability, hypotension |
Infantile parkinsonism–dystonia | 613135 | SLC6A3 | AR | Presynaptic dopamine transporter | Parkinsonism, dystonia, developmental delay, upper motor neuron signs | |
Deafness | Mohr–Tranebjaerg syndrome | 300356 | TIMM8A | X-linked | Translocase of inner mitochondrial membrane 8 | Sensorineural deafness at an early age followed by varying degrees of dystonia along with visual and cognitive disability |
Woodhouse–Sakati syndrome | 241080 | DCAF17 | AR | Nucleolar protein | Sensorineural deafness, seizures, sensory neuropathy, mental retardation, alopecia, hypogonadism, diabetes mellitus | |
Spasticity | Spastic paraplegia 35 (SPG35) | 612319 | FA2H | AR | Fatty acid 2-hydroxylase | Spasticity, cognitive decline, dystonia, optic atrophy, brain iron accumulation, leukodystrophy |
SPG2, Pelizaeus– Merzbacher disease | 312920, 312080 | PLP1 | X-linked | Proteolipid protein-1 | Spasticity, ataxia, dystonia, developmental delay, hypomyelinative leukodystrophy | |
SPG15 | ZFYVE26 | KI | AR | Spastizin | Spasticity, amyotrophy, ataxia, mental retardation, dystonia | |
Metabolic and storage | Wilson disease | 277900 | ATP7B | AR | ATPase, Cu2+ transporting β polypeptide | Hepatitis, liver failure, Kayser–Fleischer rings, tremor, dystonia, personality changes |
Lesch–Nyhan syndrome | 300322 | HPRT1 | X-linked recessive | Hypoxanthine guanine phosphoribosyl-transferase I | Hyperuricemia, gout, nephrolithiasis, self-injurious behavior, dystonia, mental retardation, athetosis | |
Glutaric academia I | 231670 | GCDH | AR | Glutaryl-CoA dehydrogenase | Macrocephaly, hepatomegaly, dystonia, choreoathetosis, infantile encephalopathy, striatal necrosis | |
Pyruvate dehydrogenase deficiency | 312170 | PDHA1 | X-linked dominant | Pyruvate dehydrogenase E1-α deficiency | Low birth weight, microcephaly, dysmorphic features, psychomotor retardation, seizures, choreoathetosis, dystonia, ataxia, lactic acidosis | |
Homocystinuria | 236200 | CBS | AR | Cystathionine β-synthase deficiency | Tall stature, ectopic lentis, skeletal abnormalities, seizures, mental retardation, dystonia, thromboembolism | |
Biotin-responsive basal ganglia disease | 607483 | AR | Subacute encephalopathy, dysphagia, dysarthria, dystonia, nystagmus, seizures | |||
Niemann–Pick type C1 | 257220 | NPC1 | AR | Neimann-Pick C1 protein | Hepatosplenomegaly, supranuclear gaze palsy, dementia, dysarthria, dystonia, ataxia | |
Niemann–Pick type C2 | 607625 | NPC2 | AR | Epididymal secretory protein E1 | Hepatosplenomegaly, respiratory failure, supranuclear gaze play, dementia, dysarthria, dystonia, ataxia | |
GM1 gangliosidosis | 230500 | GLB1 | AR | β-Galactosidase | Dysmorphic face/neck, dwarfism, macular cherry-red spot, hepatosplenomegaly, mental retardation, dystonia | |
GM2 gangliosidosis | 272750 | GM2A | AR | Ganglioside GM2 activator | Macular cherry-red spot, blindness, psychomotor delay, dementia, seizures, dystonia | |
Tay–Sachs disease | 272800 | HEXA | AR | β-Hexosaminidase, subunit α | Macular cherry-red spot, blindness, psychomotor deterioration, seizures, dementia, dystonia | |
Neuronal ceroid-lipofuscinosisa | 204200 | CLN3 | AR | Battenin | Retinitis pigmentosa with progressive vision loss, psychomotor degeneration with dementia, parkinsonism, ataxia, dystonia, seizures | |
Metachromatic leukodystrophy | 250100 | ARSA | AR | Arylsulfatase A | Optic atrophy, dementia, ataxia, chorea, dystonia, seizures, demyelinating polyneuropathy | |
Mitochondrial | Leber hereditary optic atrophy (LHON) | 53500 | MTND1b | M | NADH dehydrogenase I | Optic atrophy, action tremor, dystonia, peripheral neuropathy |
Leigh syndromec | 25600 | MTND2 | AR, M, X-linked | NAD dehydrogenase subunit 2 | Ophthalmoplegia, pigmentary retinopathy, psychomotor retardation, ataxia, dystonia, spasticity, seizures, lactic acidosis | |
Other neuro- degenerative disorders | Rett syndrome | 312750 | MECP2 | X-linked dominant | MECP2 | Mental retardation, stereotypies, parkinsonism, dystonia |
Huntington disease (HD) | 143100 | HTT | AD | Huntington | Chorea, personality changes, dementia, dystonia | |
Huntington disease-like 2 (HDL2) | 606438 | JPH3 | AD | Junctophilin 3 | Dementia, akinetic-rigid syndrome, mild chorea, mild dystonia | |
Choreoacanthocytosis | 200150 | VPS13A | AR | Chorein | Orofacial dyskinesias, dysphagia, choreoathetosis, dystonia, seizures, parkinsonism, acanthocytosis | |
Creutzfeldt–Jakob disease, familial | 123400 | PRNP | AD | Prion protein | Dementia, delirium, myoclonus, akinetic-rigid syndrome, dystonia, ataxia |
AD, autosomal dominant; AR, autosomal recessive; M, mitochondrial.
Neuronal ceroid lipofuscinoses are a group of genetically heterogeneous disorders characterized by intracellular accumulation of autofluorescent lipopigment and include dementia, movement disorders, vision loss, and seizures as phenotypic features (Getty and Pearce, 2011).
LHON has been associated with variants in ND1, ND2, ND4, ND4L, ND5, ND6, MTCYB, MTCO1, and MTAP6 (Toñska et al., 2010).
Leigh syndrome is associated with marked genetic hetereogeneity and can be caused by mutations in either mtDNA or nDNA (Finsterer, 2008).